A recent study from Singapore has delivered a powerful message: 95% of people may carry at least one gene variant that can impact how they respond to medication. This finding, published in The Pharmacogenomics Journal (2025), is a major milestone in the movement toward personalized, genomics-guided healthcare. It highlights the growing need to make pharmacogenomic (PGx) testing a routine part of primary care.